Insmed Incorporated (0JAV)
LSE
103.16
-2.80 (-2.64%)
Closed
Oct 7, 2026
Day's Range
102.00108.26
52 wk Range
91.59214.00
Financial Statements - 0JAV - Insmed Incorporated
Revenue
1.75T▲ 4.5%
Net Income
30.62B▲ 193.8%Net Margin 1.7%
EBITDA
138.66B▲ 106.3%
Free Cash Flow
11.42B▼ 81.0%
Income Statement
| Period Ending | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|
| Sales | 1.75T | 1.68T | 2T | 2.01T |
| Cost of Goods | 1.13T | 1.10T | 1.28T | 1.24T |
| Gross Profit | 622.66B | 572.30B | 721.57B | 766.88B |
 Operating Expense | - | - | - | - |
| Operating Income | 40.35B | -41.64B | 79.05B | 87.42B |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 44.38B | -41.02B | 75.89B | 83.96B |
| Income Tax | 13.76B | -8.36B | 31.47B | 28.58B |
| Net Income | 30.62B | -32.66B | 44.41B | 55.37B |
| EPS Basic | 45.35 | -45.2 | 54.58 | 68.32 |
| EPS Diluted | 45.34 | -45.2 | 54.58 | 68.32 |
| Basic Shares Outstanding | 669.69M | 724.17M | 724.59M | 724.86M |
| Diluted Shares Outstanding | 669.69M | 724.17M | 724.59M | 724.86M |
| Ebit | - | - | - | - |
| Ebitda | 138.66B | 67.20B | 204.89B | 186.21B |
| Net Income Continuous Operations | 30.62B | -32.66B | 44.41B | 55.37B |
| Minority Interests | -254M | -66M | -4.86B | -5.85B |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
